Hercules Capital Inc

Hercules Capital Inc (HTGC) News & Events

$16.370

-0.285 (-1.74%)At close

HTGC News

HTGC Events

10/6 16:30

Rocket Pharmaceuticals Enters $150 Million Credit Facility with Hercules Capital

Rocket Pharmaceuticals (RCKT) "announced that it has entered into a credit facility agreement with Hercules Capital (HTGC) for up to $150 million. The facility strengthens Rocket's financial position and provides access to additional capital to support execution of its pivotal Phase 2 study of RP-A501 for Danon disease and continued advancement of its broader cardiovascular pipeline."

9/29 07:30

NorthStar Medical Technologies Signs Up to $185M Growth Capital Facility with Hercules Capital

NorthStar Medical Technologies announced a multi-year growth capital facility of up to $185M with Hercules Capital to support NorthStar's continued growth and expansion. The financing, including $100M upfront, will accelerate investment in isotope production and in clinical and commercial drug manufacturing capabilities, enabling NorthStar's pharmaceutical and biotechnology partners to advance next-generation precision cancer therapies to patients worldwide. The agreement supports NorthStar's continued commercial scale-up investment leveraging its industry-leading scientific talent and vertically integrated radiopharmaceutical campus, where it provides clinical and commercial isotope production and radiopharmaceutical manufacturing, including comprehensive cGMP services through its state-of-the-art CDMO.

7/30 16:30

Hercules Capital Reports Q2 NII of 50c, Beating Consensus of 48c

Hercules Capital reports Q2 NII 50c, consensus 48c

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading